bioAffinity Technologies
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of bioAffinity Technologies generated cash of -$6,037,806, which is less than the previous year. Cash used in financing activities reached the amount of -$344,984 last year. Net change in cash is therefore -$8,592,189.
Cash Flow
| 2019 | -2.49M | -11.39K | 2.33M |
|---|---|---|---|
| 2020 | -2.20M | -2.88K | 1.71M |
| 2021 | -2.04M | 0 | 3.32M |
| 2022 | -4.07M | -219.98K | 14.34M |
| 2023 | -6.03M | -2.20M | -344.98K |
BIAF Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 11.41M | 1.36M | 83.10K | 578.48K | 745.07K |
Operating activities | |||||
Net income | -7.93M | -8.15M | -6.32M | -7.26M | -3.30M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 249.59K | 10.18K | 4.81K | 22.24K | 40.27K |
Stock-based compensation expense | 748.82K | 248.59K | 43.01K | 275.73K | 0 |
| Deferred income tax benefit | 748.82K | 248.59K | 43.01K | 275.73K | 0 |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 311.36K | -8.95K | 0 | 0 | 290 |
Inventories | 0 | -5.54K | 0 | 0 | 0 |
Accounts payable | -14.50K | 114.63K | 39.02K | 87.96K | -39.82K |
Cash generated by operating activities | -6.03M | -4.07M | -2.04M | -2.20M | -2.49M |
Investing activities | |||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -22.90K | -219.98K | 0 | -2.88K | -11.39K |
Acquisitions Net | -2.18M | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -2.20M | -219.98K | 0 | -2.88K | -11.39K |
Financing activities | |||||
Common Stock Issued | 0 | 6.02M | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -344.98K | 584.16K | -3.50M | -1.71M | 0 |
Cash used in financing activities | -344.98K | 14.34M | 3.32M | 1.71M | 2.33M |
Net Change In Cash | -8.59M | 10.05M | 1.27M | -495.37K | -166.59K |
Cash at end of period | 2.82M | 11.41M | 1.36M | 83.10K | 578.48K |
| Data source | Data source |